- £256.71m
- £426.21m
- £316.40m
- 68
- 53
- 25
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 200 | 233 | 240 | 290 | 316 |
Cost of Revenue | |||||
Gross Profit | 90.1 | 110 | 108 | 121 | 131 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 173 | 196 | 211 | 315 | 292 |
Operating Profit | 26.7 | 37.4 | 29.7 | -24.1 | 24.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24 | 35.7 | 28.4 | -30.2 | 11.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.8 | 31.7 | 23 | -19.6 | -9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.5 | 31.5 | 22.6 | -20 | -9.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 20.5 | 31.5 | 22.6 | -20 | -9.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.31 | 1.92 | 1.91 | 2.82 | -0.36 |
Dividends per Share |